New combo therapy targets hard-to-treat lymphoma
NCT ID NCT07059650
First seen Apr 04, 2026 · Last updated May 16, 2026 · Updated 6 times
Summary
This study tests a new drug called DZD8586 combined with standard treatments for diffuse large B-cell lymphoma (DLBCL), a fast-growing blood cancer. About 150 adults with either untreated or relapsed/refractory DLBCL will receive the combination. Researchers will measure how well the drug shrinks tumors and check for side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIFFUSE LARGE B CELL LYMPHOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Anhui Provincial Cancer Hospital
RECRUITINGHefei, China
Contact Email: •••••@•••••
-
Guangdong Provincial People's Hospital
RECRUITINGGuangzhou, China
Contact Email: •••••@•••••
-
Henan Cancer Hospital
RECRUITINGZhengzhou, China
Contact Email: •••••@•••••
-
Hunan Cancer Hospital
NOT_YET_RECRUITINGChangsha, China
Contact Email: •••••@•••••
-
Linyi Cancer Hospital
RECRUITINGLinyi, China
Contact Email: •••••@•••••
-
Peking University Third Hospital
RECRUITINGBeijing, China
Contact Email: •••••@•••••
-
Shanxi Cancer Hospital
RECRUITINGTaiyuan, China
Contact Email: •••••@•••••
-
Sun Yat-sen University Cancer Center
RECRUITINGGuangzhou, China
Contact Email: •••••@•••••
-
The First Affiliated Hospital of Xi'an Jiaotong University
RECRUITINGXi'an, China
Contact Email: •••••@•••••
-
The Second Affiliated Hospital Zhejiang University School of Medicine
RECRUITINGHangzhou, China
Contact Email: •••••@•••••
-
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
RECRUITINGWuhan, China
Contact Email: •••••@•••••
-
West China Hospital of Sichuan University
RECRUITINGChengdu, China
Contact Email: •••••@•••••
-
Zhujiang Hospital of Southern Medical University
RECRUITINGGuangzhou, China
Contact Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.